BioCentury
ARTICLE | Clinical News

VistaGen preclinical data

December 11, 2006 8:00 AM UTC

VistaGen said preclinical studies suggest that AV-101 can stimulate the firing of dopaminergic neurons, the neurons that die in PD. ...